Oligo & Peptide Market Leader, Life Sciences

CRB; United States; On-site; USD 150,000 - 190,000; Full time

Job summary

CRB is seeking a Director, Oligo & Peptide Market Segment Leader to steer global strategy and growth for the Oligo & Peptides market across regions. The role emphasizes leadership of a cross-functional team, advancing CRB’s presence, and shaping strategic opportunities with clients and regulatory bodies.

With 15+ years in design/construction and 10+ years in life sciences, you will mentor teams, drive thought leadership, and collaborate with senior leadership to differentiate CRB through

Qualifications

• 15+ years in design/construction industry.
• 10+ years in life sciences industry with understanding of life science facility operations.

Responsibilities

• Strategize industry trends and identify evolution pathways for therapeutic science and manufacturing methods.
• Be CRB’s face for Oligo & Peptides, building brand and reputation across regions.
• Increase market capture by aligning with Business Development and Sales Services on strategy and proposals.
• Strengthen CRB’s design capabilities through internal training and mentoring programs.
• Grow CRB’s regulatory expertise and engage with global regulatory bodies.

Skills

Leadership

Strategic thinking

Public speaking

Technical writing

Industry knowledge

Mentorship

Market development

Relationship building

Cross-functional leadership

Client engagement

Education

Bachelor’s degree in architecture/engineering/construction/science

Job description

CRB is seeking a Director, Oligo & Peptide Market Segment Leader to steer global strategy and growth for the Oligo & Peptides market across regions. The role emphasizes leadership of a cross-functional team, advancing CRB’s presence, and shaping strategic opportunities with clients and regulatory bodies.

With 15+ years in design/construction and 10+ years in life sciences, you will mentor teams, drive thought leadership, and collaborate with senior leadership to differentiate CRB through